The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Peripheral Drug-Coated Balloon-Global Market Insights and Sales Trends 2024
Synopsis
Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”.
The global Peripheral Drug-Coated Balloon market size is expected to reach US$ 1363.8 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Peripheral Drug-Coated Balloon in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Peripheral Drug-Coated Balloon market. Paclitaxel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sirolimus segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Peripheral Drug-Coated Balloon, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Peripheral Drug-Coated Balloon market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Peripheral Drug-Coated Balloon market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Peripheral Drug-Coated Balloon sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Peripheral Drug-Coated Balloon covered in this report include Cordis, Defibtech, Abbott Laboratories, REVA Medical, Shimadzu, Opto Circuits, Biotronik, Endologix and SMT, etc.
The global Peripheral Drug-Coated Balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cordis
Defibtech
Abbott Laboratories
REVA Medical
Shimadzu
Opto Circuits
Biotronik
Endologix
SMT
Philips Healthcare
Elixir Medical
CorMatrix Cardiovascular
Advanced Cardiac Therapeutics
Edwards Lifesciences
Impulse Dynamics
Stereotaxis
Global Peripheral Drug-Coated Balloon market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Peripheral Drug-Coated Balloon market, Segment by Type:
Paclitaxel
Sirolimus
Others
Global Peripheral Drug-Coated Balloon market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Peripheral Drug-Coated Balloon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Peripheral Drug-Coated Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”.
The global Peripheral Drug-Coated Balloon market size is expected to reach US$ 1363.8 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Peripheral Drug-Coated Balloon in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Peripheral Drug-Coated Balloon market. Paclitaxel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sirolimus segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Peripheral Drug-Coated Balloon, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Peripheral Drug-Coated Balloon market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Peripheral Drug-Coated Balloon market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Peripheral Drug-Coated Balloon sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Peripheral Drug-Coated Balloon covered in this report include Cordis, Defibtech, Abbott Laboratories, REVA Medical, Shimadzu, Opto Circuits, Biotronik, Endologix and SMT, etc.
The global Peripheral Drug-Coated Balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cordis
Defibtech
Abbott Laboratories
REVA Medical
Shimadzu
Opto Circuits
Biotronik
Endologix
SMT
Philips Healthcare
Elixir Medical
CorMatrix Cardiovascular
Advanced Cardiac Therapeutics
Edwards Lifesciences
Impulse Dynamics
Stereotaxis
Global Peripheral Drug-Coated Balloon market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Peripheral Drug-Coated Balloon market, Segment by Type:
Paclitaxel
Sirolimus
Others
Global Peripheral Drug-Coated Balloon market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Peripheral Drug-Coated Balloon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Peripheral Drug-Coated Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Peripheral Drug-Coated Balloon Market Overview
1.1 Peripheral Drug-Coated Balloon Product Overview
1.2 Peripheral Drug-Coated Balloon Market Segment by Type
1.2.1 Paclitaxel
1.2.2 Sirolimus
1.2.3 Others
1.3 Global Peripheral Drug-Coated Balloon Market Size by Type
1.3.1 Global Peripheral Drug-Coated Balloon Market Size Overview by Type (2018-2029)
1.3.2 Global Peripheral Drug-Coated Balloon Historic Market Size Review by Type (2018-2023)
1.3.3 Global Peripheral Drug-Coated Balloon Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Peripheral Drug-Coated Balloon Sales Breakdown by Type (2018-2023)
1.4.2 Europe Peripheral Drug-Coated Balloon Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Peripheral Drug-Coated Balloon Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Peripheral Drug-Coated Balloon Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Peripheral Drug-Coated Balloon Sales Breakdown by Type (2018-2023)
2 Global Peripheral Drug-Coated Balloon Market Competition by Company
2.1 Global Top Players by Peripheral Drug-Coated Balloon Sales (2018-2023)
2.2 Global Top Players by Peripheral Drug-Coated Balloon Revenue (2018-2023)
2.3 Global Top Players by Peripheral Drug-Coated Balloon Price (2018-2023)
2.4 Global Top Manufacturers Peripheral Drug-Coated Balloon Manufacturing Base Distribution, Sales Area, Product Type
2.5 Peripheral Drug-Coated Balloon Market Competitive Situation and Trends
2.5.1 Peripheral Drug-Coated Balloon Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Peripheral Drug-Coated Balloon Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Drug-Coated Balloon as of 2022)
2.7 Date of Key Manufacturers Enter into Peripheral Drug-Coated Balloon Market
2.8 Key Manufacturers Peripheral Drug-Coated Balloon Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Peripheral Drug-Coated Balloon Status and Outlook by Region
3.1 Global Peripheral Drug-Coated Balloon Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Peripheral Drug-Coated Balloon Historic Market Size by Region
3.2.1 Global Peripheral Drug-Coated Balloon Sales in Volume by Region (2018-2023)
3.2.2 Global Peripheral Drug-Coated Balloon Sales in Value by Region (2018-2023)
3.2.3 Global Peripheral Drug-Coated Balloon Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Peripheral Drug-Coated Balloon Forecasted Market Size by Region
3.3.1 Global Peripheral Drug-Coated Balloon Sales in Volume by Region (2024-2029)
3.3.2 Global Peripheral Drug-Coated Balloon Sales in Value by Region (2024-2029)
3.3.3 Global Peripheral Drug-Coated Balloon Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Peripheral Drug-Coated Balloon by Application
4.1 Peripheral Drug-Coated Balloon Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Peripheral Drug-Coated Balloon Market Size by Application
4.2.1 Global Peripheral Drug-Coated Balloon Market Size Overview by Application (2018-2029)
4.2.2 Global Peripheral Drug-Coated Balloon Historic Market Size Review by Application (2018-2023)
4.2.3 Global Peripheral Drug-Coated Balloon Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Peripheral Drug-Coated Balloon Sales Breakdown by Application (2018-2023)
4.3.2 Europe Peripheral Drug-Coated Balloon Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Peripheral Drug-Coated Balloon Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Peripheral Drug-Coated Balloon Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Peripheral Drug-Coated Balloon Sales Breakdown by Application (2018-2023)
5 North America Peripheral Drug-Coated Balloon by Country
5.1 North America Peripheral Drug-Coated Balloon Historic Market Size by Country
5.1.1 North America Peripheral Drug-Coated Balloon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Peripheral Drug-Coated Balloon Sales in Volume by Country (2018-2023)
5.1.3 North America Peripheral Drug-Coated Balloon Sales in Value by Country (2018-2023)
5.2 North America Peripheral Drug-Coated Balloon Forecasted Market Size by Country
5.2.1 North America Peripheral Drug-Coated Balloon Sales in Volume by Country (2024-2029)
5.2.2 North America Peripheral Drug-Coated Balloon Sales in Value by Country (2024-2029)
6 Europe Peripheral Drug-Coated Balloon by Country
6.1 Europe Peripheral Drug-Coated Balloon Historic Market Size by Country
6.1.1 Europe Peripheral Drug-Coated Balloon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Peripheral Drug-Coated Balloon Sales in Volume by Country (2018-2023)
6.1.3 Europe Peripheral Drug-Coated Balloon Sales in Value by Country (2018-2023)
6.2 Europe Peripheral Drug-Coated Balloon Forecasted Market Size by Country
6.2.1 Europe Peripheral Drug-Coated Balloon Sales in Volume by Country (2024-2029)
6.2.2 Europe Peripheral Drug-Coated Balloon Sales in Value by Country (2024-2029)
7 Asia-Pacific Peripheral Drug-Coated Balloon by Region
7.1 Asia-Pacific Peripheral Drug-Coated Balloon Historic Market Size by Region
7.1.1 Asia-Pacific Peripheral Drug-Coated Balloon Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Peripheral Drug-Coated Balloon Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Peripheral Drug-Coated Balloon Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Peripheral Drug-Coated Balloon Forecasted Market Size by Region
7.2.1 Asia-Pacific Peripheral Drug-Coated Balloon Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Peripheral Drug-Coated Balloon Sales in Value by Region (2024-2029)
8 Latin America Peripheral Drug-Coated Balloon by Country
8.1 Latin America Peripheral Drug-Coated Balloon Historic Market Size by Country
8.1.1 Latin America Peripheral Drug-Coated Balloon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Peripheral Drug-Coated Balloon Sales in Volume by Country (2018-2023)
8.1.3 Latin America Peripheral Drug-Coated Balloon Sales in Value by Country (2018-2023)
8.2 Latin America Peripheral Drug-Coated Balloon Forecasted Market Size by Country
8.2.1 Latin America Peripheral Drug-Coated Balloon Sales in Volume by Country (2024-2029)
8.2.2 Latin America Peripheral Drug-Coated Balloon Sales in Value by Country (2024-2029)
9 Middle East and Africa Peripheral Drug-Coated Balloon by Country
9.1 Middle East and Africa Peripheral Drug-Coated Balloon Historic Market Size by Country
9.1.1 Middle East and Africa Peripheral Drug-Coated Balloon Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Peripheral Drug-Coated Balloon Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Peripheral Drug-Coated Balloon Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Peripheral Drug-Coated Balloon Forecasted Market Size by Country
9.2.1 Middle East and Africa Peripheral Drug-Coated Balloon Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Peripheral Drug-Coated Balloon Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Cordis
10.1.1 Cordis Company Information
10.1.2 Cordis Introduction and Business Overview
10.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Cordis Peripheral Drug-Coated Balloon Products Offered
10.1.5 Cordis Recent Development
10.2 Defibtech
10.2.1 Defibtech Company Information
10.2.2 Defibtech Introduction and Business Overview
10.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Defibtech Peripheral Drug-Coated Balloon Products Offered
10.2.5 Defibtech Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Information
10.3.2 Abbott Laboratories Introduction and Business Overview
10.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Laboratories Peripheral Drug-Coated Balloon Products Offered
10.3.5 Abbott Laboratories Recent Development
10.4 REVA Medical
10.4.1 REVA Medical Company Information
10.4.2 REVA Medical Introduction and Business Overview
10.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.4.4 REVA Medical Peripheral Drug-Coated Balloon Products Offered
10.4.5 REVA Medical Recent Development
10.5 Shimadzu
10.5.1 Shimadzu Company Information
10.5.2 Shimadzu Introduction and Business Overview
10.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Shimadzu Peripheral Drug-Coated Balloon Products Offered
10.5.5 Shimadzu Recent Development
10.6 Opto Circuits
10.6.1 Opto Circuits Company Information
10.6.2 Opto Circuits Introduction and Business Overview
10.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Opto Circuits Peripheral Drug-Coated Balloon Products Offered
10.6.5 Opto Circuits Recent Development
10.7 Biotronik
10.7.1 Biotronik Company Information
10.7.2 Biotronik Introduction and Business Overview
10.7.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biotronik Peripheral Drug-Coated Balloon Products Offered
10.7.5 Biotronik Recent Development
10.8 Endologix
10.8.1 Endologix Company Information
10.8.2 Endologix Introduction and Business Overview
10.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Endologix Peripheral Drug-Coated Balloon Products Offered
10.8.5 Endologix Recent Development
10.9 SMT
10.9.1 SMT Company Information
10.9.2 SMT Introduction and Business Overview
10.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SMT Peripheral Drug-Coated Balloon Products Offered
10.9.5 SMT Recent Development
10.10 Philips Healthcare
10.10.1 Philips Healthcare Company Information
10.10.2 Philips Healthcare Introduction and Business Overview
10.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Philips Healthcare Peripheral Drug-Coated Balloon Products Offered
10.10.5 Philips Healthcare Recent Development
10.11 Elixir Medical
10.11.1 Elixir Medical Company Information
10.11.2 Elixir Medical Introduction and Business Overview
10.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Elixir Medical Peripheral Drug-Coated Balloon Products Offered
10.11.5 Elixir Medical Recent Development
10.12 CorMatrix Cardiovascular
10.12.1 CorMatrix Cardiovascular Company Information
10.12.2 CorMatrix Cardiovascular Introduction and Business Overview
10.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Products Offered
10.12.5 CorMatrix Cardiovascular Recent Development
10.13 Advanced Cardiac Therapeutics
10.13.1 Advanced Cardiac Therapeutics Company Information
10.13.2 Advanced Cardiac Therapeutics Introduction and Business Overview
10.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Products Offered
10.13.5 Advanced Cardiac Therapeutics Recent Development
10.14 Edwards Lifesciences
10.14.1 Edwards Lifesciences Company Information
10.14.2 Edwards Lifesciences Introduction and Business Overview
10.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Edwards Lifesciences Peripheral Drug-Coated Balloon Products Offered
10.14.5 Edwards Lifesciences Recent Development
10.15 Impulse Dynamics
10.15.1 Impulse Dynamics Company Information
10.15.2 Impulse Dynamics Introduction and Business Overview
10.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Impulse Dynamics Peripheral Drug-Coated Balloon Products Offered
10.15.5 Impulse Dynamics Recent Development
10.16 Stereotaxis
10.16.1 Stereotaxis Company Information
10.16.2 Stereotaxis Introduction and Business Overview
10.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Stereotaxis Peripheral Drug-Coated Balloon Products Offered
10.16.5 Stereotaxis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Peripheral Drug-Coated Balloon Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Peripheral Drug-Coated Balloon Industrial Chain Analysis
11.4 Peripheral Drug-Coated Balloon Market Dynamics
11.4.1 Peripheral Drug-Coated Balloon Industry Trends
11.4.2 Peripheral Drug-Coated Balloon Market Drivers
11.4.3 Peripheral Drug-Coated Balloon Market Challenges
11.4.4 Peripheral Drug-Coated Balloon Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Peripheral Drug-Coated Balloon Distributors
12.3 Peripheral Drug-Coated Balloon Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
